Axogen, Inc. (AXGN) Dividend History

Axogen, Inc. is a biotechnology company focused on the development and commercialization of surgical grafts to repair, replace, or regenerate peripheral nerve tissue. The company specializes in products aimed at nerve repair and regeneration, providing solutions for nerve injuries resulting from surgery, trauma, and other conditions. Based in Florida, Axogen aims to improve functional outcomes for patients with nerve damage.

13631 Progress Blvd., Alachua, FL, 32615
Phone: (386) 462-6817
Website:

Dividend History

Pay Date Amount Ex Dividend Date Record Date
February 12, 2010 $1.00 01/27/2010 01/29/2010
March 11, 2005 $0.06 02/23/2005 02/25/2005

Dividends Summary

  • Axogen, Inc. has issued 2 dividend payments over the past 5 years
  • The most recent dividend was paid 5594 days ago, on February 12, 2010
  • The first recorded dividend was paid on March 11, 2005
  • The highest dividend payout was $1.00 per share
  • The average dividend over this 5 year span is $0.53 per share
  • Axogen, Inc. has increased its dividend payments by 1566.67% since 2005

Company News

  • Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, will report its 2024 fourth quarter and full year financial results on February 25, 2025. The company will host an investment-community conference call and webcast to discuss the results.

    GlobeNewswire Inc.
  • Bruker Corporation announced the acquisition of Dynamic Biosensors GmbH, a company known for its development in biosensors. The acquisition is expected to strengthen Bruker's position in the pharma and biotech industries by leveraging its leading high-throughput Surface Plasmon Resonance portfolio and Dynamic Biosensors' unique instruments.

    Benzinga
    Featured Companies: BRKR KIDS TMDX
  • Bruker Corporation's growth is backed by strong sales in its X-Ray and Nano Analytics businesses, as well as increasing customer demand for its preclinical MRI systems. However, the company faces challenges from macroeconomic pressures and currency fluctuations.

    Benzinga
    Featured Companies: BRKR
  • The article discusses how September has historically been a weak month for the stock market, but this year the S&P 500, Dow, and Nasdaq have gained over 1% so far, breaking a 5-year trend. The author recommends buying three breakout stocks that could take advantage of the broader market's upward movement: Bioventus (BVS), Great Lakes Dredge & Dock (GLDD), and AxoGen (AXGN).

    Benzinga
    Featured Companies: BVS
  • Inogen is well-positioned for growth in the portable oxygen concentrator (POC) market, with a strong product portfolio and solid Q2 results. However, it faces stiff competition and forex volatility. The company's stock has outperformed the industry and the S&P 500 year-to-date.

    Benzinga
    Featured Companies: INGN SIBN
Dividend data last updated 06/07/2025 00:47:25 UTC